Differential effects of lipid-lowering agents on human cholinesterases
- 1 January 2004
- journal article
- Published by Elsevier in Clinical Biochemistry
- Vol. 37 (1) , 42-49
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Neurobiology of butyrylcholinesteraseNature Reviews Neuroscience, 2003
- Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefitJournal of Neural Transmission, 2002
- A New Therapeutic Target in Alzheimer's Disease Treatment: Attention to ButyrylcholinesteraseCurrent Medical Research and Opinion, 2001
- The effects of lacidipine on the steady/state plasma concentrations of simvastatin in healthy subjectsBritish Journal of Clinical Pharmacology, 2001
- Butyrylcholinesterase in the life cycle of amyloid plaquesAnnals of Neurology, 1997
- Butyrylcholinesterase reactivity differentiates the amyloid plaques of aging from those of dementiaAnnals of Neurology, 1994
- Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development—A study of molecular formsNeurochemistry International, 1992
- Alzheimer's Disease: A Disorder of Cortical Cholinergic InnervationScience, 1983
- The Cholinergic Hypothesis of Geriatric Memory DysfunctionScience, 1982
- Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalisAnnals of Neurology, 1981